Correction: Current Oncology Reports
https://doi.org/10.1007/s11912-022-01201-7
The original version of this article unfortunately contained a mistake in the title of Table 1, which originally read “Marissa Barbarolderly Glioblastoma Patient Trials.” The correct caption is shown below, and the original article has been corrected accordingly.
Table 1. Elderly Glioblastoma Patient Trials
There is also an error in the first sentence under ‘Future Directions’ section that should be corrected with the following.
Novel therapeutic approaches are needed in eGBM as prognosis remains dismal. Immunotherapy has revolutionized cancer therapy, but has yet to show survival benefit in GBM or eGBM [37].
Footnotes
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Contributor Information
Carlen A. Yuen, Email: cay2115@cumc.columbia.edu
Marissa Barbaro, Email: marissa.barbaro@nyulangone.org.
Aya Haggiagi, Email: amh2237@cumc.columbia.edu.